Top U.S. health officials defend third-world H.I.V. research.
D002487:Centers for Disease Control and Prevention, U.S.; D032781:Codes of Ethics; D003906:Developing Countries; D004467:Economics; D028781:Ethical Relativism; D004989:Ethics; D004995:Ethics, Professional; D035082:Federal Government; D005378:Financial Support; D006076:Government; D006679:HIV Seropositivity; D006805:Human Experimentation; D006801:Humans; D007231:Infant, Newborn; D007258:Informed Consent; D007391:International Cooperation; D038622:Internationality; D009316:National Institutes of Health (U.S.); D004364:Pharmaceutical Preparations; D010919:Placebos; D011247:Pregnancy; D037841:Pregnant People; D011315:Preventive Medicine; D012106:Research; D012107:Research Design; D015871:Scientific Misconduct; D036302:Therapeutic Human Experimentation; D014481:United States; D015215:Zidovudine
Biomedical and Behavioral Research; Centers for Disease Control and Prevention; Health Care and Public Health; National Institutes of Health; Popular Approach/Source